he said that Lucentis brings in $2 billion for DRY AMD, when in fact the label is for wet.
In the Rodman and Renshaw presentation he clearly said there were no (FDA) approved treatments for Dry AMD. He separately said that the dry AMD market is (potentially - given that there are no approved treatments for dry AMD) much larger than the wet AMD market - and in the wet AMD market Lucentis is doing $2B/Year.
PP – If you want to get a feel for this company and its junk science, listen to the 3Q07 CC from three days ago. If you listen to it and come away with the opinion that the company is legit, please let me know. Regards, Dew
p.s. You can skip over the longwinded prepared remarks and go directly the Q&A without missing anything.
Market Data 
Markets 
AI
